Binciken da ya ƙunshi manya 50 masu shekaru 40‑64 masu kiba ya nuna cewa shan 1,000 mg na urolithin A a kowace rana tsawon makonni huɗu ba ya haɓaka faɗuwar jijiyar brachial (FMD) ko kuma canza aikin microvascular a ƙasa. Sai dai amsar hawan jini a kwakwalwa yayin aiki tana da ƙarfi sosai a ƙungiyar da ta samu urolithin A idan aka kwatanta da placebo, duk da cewa aikin kwakwalwa ba ya ƙaruwa. Wannan sakamako na biyu yana nuni da wata alamar abin sha'awa, amma ba ya ba da hujjar ƙarshe kan amfanin kari. Anan za mu kawo abin da binciken ya nuna, abin da ya rage a bayyane, da kuma abin da ke nufin ga masu tunanin ɗaukar wannan ƙari.
This page is available in
